Article Information
History
- January 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- David Camerini1,2,†,
- Arlo Z. Randall1,
- Krista Trappl-Kimmons1,
- Amit Oberai1,
- Christopher Hung1,
- Joshua Edgar1,
- Adam Shandling1,
- Vu Huynh1,
- Andy A. Teng1,
- Gary Hermanson1,
- Jozelyn V. Pablo1,
- Megan M. Stumpf3,
- Sandra N. Lester3,
- Jennifer Harcourt3,
- Azaibi Tamin3,
- Mohammed Rasheed3,
- Natalie J. Thornburg3,
- Panayampalli S. Satheshkumar3,
- Xiaowu Liang1,
- Richard B. Kennedy4,
- Angela Yee1,
- Michael Townsend3,* and
- Joseph J. Campo1,*
- 1Antigen Discovery Incorporated (ADI), Irvine CA
- 2University of California, Irvine, CA
- 3Centers for Disease Control and Prevention, Atlanta, GA
- 4Mayo Clinic, Rochester, MN
- ↵† Corresponding author; email: dcamerini{at}antigendiscovery.com
Posted January 15, 2021.
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
